A rating of 98 puts Oncolytics Biotech, Inc. (ONCY) near the top of the Biotechnology industry according to InvestorsObserver. Oncolytics Biotech, Inc.'s score of 98 means it scores higher than 98% of stocks in the industry. Oncolytics Biotech, Inc. also received an overall rating of 83, putting it above 83% of all stocks. Biotechnology is ranked 37 out of the 148 industries.
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 83 would rank higher than 83 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.
Oncolytics Biotech, Inc. (ONCY) stock is trading at $3.91 as of 11:51 AM on Friday, Dec 4, an increase of $0.28, or 7.71% from the previous closing price of $3.63. The stock has traded between $3.63 and $3.95 so far today. Volume today is 1,004,118 compared to average volume of 1,138,833.
Click Here to get the full Stock Score Report on Oncolytics Biotech, Inc. (ONCY) Stock.
Recommendation and review posted by G. Smith
